Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DM0MTP8)

Drug Name
CN-105 Drug Info
Synonyms
5-Nitroisoquinoline; 607-32-9; Isoquinoline, 5-nitro-; 5-Nitro-isoquinoline; MLS002637661; PYGMPFQCCWBTJQ-UHFFFAOYSA-N; 5-nitroisochinolin; EINECS 210-133-8; 5-nitro isoquinoline; PubChem6272; AI3-61887; Maybridge1_001820; ACMC-1AV1Q; AC1Q1X2S; 5-Nitroisoquinoline, 98%; Oprea1_032003; SCHEMBL1010663; AC1Q201M; AC1L2B31; CHEMBL353253; PYGMPFQCCWBTJQ-UHFFFAOYSA-; KS-00000DJC; CTK2F2846; ZINC93213; HMS546K16; DTXSID00209511; NSC3017; MolPort-001-761-771; HMS3078A13; ACT09900; ALBB-021274; NSC-3017; ANW-33564; SBB066313; MFCD00006905
Indication
Disease Entry ICD 11 Status REF
Nontraumatic intracerebral hemorrhage 8B00.4 Phase 2 [1]
Cross-matching ID
PubChem CID
69085
CAS Number
CAS 607-32-9
TTD Drug ID
DM0MTP8

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Discontinued Drug(s)
Download the Complete Related Drug List
Drug(s) Targeting Apolipoprotein E (APOE)
Drug Name Drug ID Indication ICD 11 Highest Status REF
AEM-28 DMI5TXZ Familial hypercholesterolemia 5C80.00 Phase 2 [2]
LX1001 DMXEJZO Alzheimer disease 8A20 Phase 1/2 [3]
Apolipoprotein E DMIYTPE Glaucoma/ocular hypertension 9C61 Terminated [4]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas
Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Apolipoprotein E (APOE) TTKS9CB APOE_HUMAN Agonist [1]

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 Clinical pipeline report, company report or official report of LipimetiX.
3 Clinical pipeline report, company report or official report of Lexeo Therapeutics
4 Apolipoprotein E: a potent inhibitor of endothelial and tumor cell proliferation. J Cell Biochem. 1994 Mar;54(3):299-308.